Alpine Global Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Alpine Global Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,268	Closed	-$745K	–	217
2024 Q4	$745K	Buy	+8,268	New	+$801K	0.22%	63
2024 Q3	–	Sell	-6,599	Closed	-$612K	–	480
2024 Q2	$612K	Buy	+6,599	New	+$592K	0.11%	160
2022 Q1	–	Sell	-52,818	Closed	-$6.58M	–	737
2021 Q4	$6.58M	Buy	+52,818	New	+$6.37M	0.97%	15
2021 Q3	–	Sell	-30,052	Closed	-$4.07M	–	375
2021 Q2	$4.07M	Buy	+30,052	New	+$3.95M	0.55%	42
2020 Q4	–	Sell	-26,340	Closed	-$2.94M	–	308
2020 Q3	$2.94M	Buy	+26,340	New	+$2.95M	0.61%	25
2020 Q1	–	Sell	-4,499	Closed	-$428K	–	448
2019 Q4	$428K	Sell	4,499 -1,379	-23%	-$119K	0.09%	186
2019 Q3	$448K	Sell	5,878 -797	-12%	-$66.2K	0.11%	44
2019 Q2	$585K	Buy	+6,675	New	+$569K	0.17%	43
2018 Q3	–	Sell	-4,804	Closed	-$457K	–	97
2018 Q2	$457K	Buy	+4,804	New	+$442K	0.22%	42
2017 Q4	–	Sell	-7,827	Closed	-$678K	–	284
2017 Q3	$678K	Buy	+7,827	New	+$627K	0.2%	78
2017 Q2	–	Sell	-8,279	Closed	-$574K	–	326
2017 Q1	$574K	Buy	+8,279	New	+$556K	0.15%	115
2016 Q2	–	Sell	-5,801	Closed	-$300K	–	255
2016 Q1	$300K	Buy	+5,801	New	+$301K	0.07%	93
2015 Q4	–	Sell	-17,945	Closed	-$1.12M	–	150
2015 Q3	$1.12M	Buy	17,945 +10,394	+138%	+$819K	0.33%	33
2015 Q2	$635K	Buy	+7,551	New	+$587K	0.11%	152

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Alpine Global Management's XBI Position: Q1 2025 in Review

Alpine Global Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 8,268 shares — an estimated $745K sold.

Alpine Global Management first reported a position in XBI in Q2 2015 and held it in 14 quarters. The position peaked at $6.58M in Q4 2021. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Alpine Global Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Alpine Global Management sold 8,268 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $745K.
Alpine Global Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 14 quarters.
Alpine Global Management's State Street SPDR S&P Biotech ETF position peaked at $6.58M in Q4 2021.
685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Alpine Global Management's 13F filing for Q1 2025, filed 15 May 2025.